top of page

GOP Senator Wants Feds To Study Hospital Costs Caused By Marijuana Use

  • Writer: Bob Marley
    Bob Marley
  • Dec 18, 2025
  • 2 min read

A Republican senator has filed an amendment that would require the federal government to track the cost of hospitalization due to marijuana use.

The proposal, from Sen. Ted Budd (R-NC), would require the secretary of the Department of Health and Human Services (HHS) to compile data on “Federal and State expenditures under the Medicaid program…that are attributable to costs incurred for providing medical assistance for inpatient hospital services, outpatient hospital services, and for services received at a hospital emergency room…related to marijuana use.”

The information would be due in the form of a report to Congress within one year of the measure being enacted, along with any recommendations for legislation and administrative action that the HHS secretary determines to be appropriate.

Legalization opponents have often claimed that cannabis drives an increase in hospital visits due to accidents and over-intoxication. Budd and other GOP senators sent a letter this week urging President Donald Trump not to follow through with plans to federally reschedule marijuana.

The senator wants to attach the measure, which he filed on Tuesday, to spending legislation that would fund parts of the federal government for Fiscal Year 2026 that is currently awaiting Senate floor action.

The full text of Budd’s marijuana amendment reads:

“Sec. ____. The Secretary of Health and Human Services (in this section referred to as the ‘Secretary’) shall collect data relating to the amount of Federal and State expenditures under the Medicaid program established under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.) that are attributable to costs incurred for providing medical assistance for inpatient hospital services, outpatient hospital services, and for services received at a hospital emergency room (without regard to whether such services are emergency services (as defined by the Secretary)) related to marijuana use (as defined by the Secretary). Not later than 1 year after the date of enactment of this division, the Secretary shall submit a report to Congress that includes such data and recommendations for such legislation and administrative action as the Secretary determines appropriate.”

It’s not clear if the amendment will receive a vote on the Senate floor.

Recent Posts

See All

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page